MedDataX Logo

Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma

NCT ID: NCT00775957

Last Updated: 2010-09-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

35 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study to determine the accuracy of FLT-PET in quantifying tumor cell proliferation at the initial staging of patients with Non-Hodgkin's Lymphoma in comparison wit the "gold standard" FDG-PET.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The first primary objective reflects a necessary and preliminary requirement: to reproduce published results and validate the use of FLT-PET. In this study, 35 patients will be selected to undergoing imaging with both FLT and FDG PET.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-Hodgkin's Lymphoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

FLT-PET Scan

FLT-PET scan

Intervention Type PROCEDURE

imaging scan

2

FDG-PET Scan

FDG-PET scan

Intervention Type PROCEDURE

imaging scan

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FLT-PET scan

imaging scan

Intervention Type PROCEDURE

FDG-PET scan

imaging scan

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
* Women must not be pregnant or breast feeding
* Histologic diagnosis of non-Hodgkin's lymphoma (any stage)
* Must undergo treatment with chemotherapy and/or radiotherapy

Exclusion Criteria

* May not have received previous therapy with radiopharmaceuticals
* May not have received prior therapy with cytotoxic chemotherapy and/or monoclonal antibodies
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Midwest Medical Isotopes

UNKNOWN

Sponsor Role collaborator

University of Oklahoma

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Oklahoma Health Sciences Center- Dept. of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FLT-NHL

Identifier Type: -

Identifier Source: org_study_id